Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Inflammation × Sufentanil × Clear all

Phase

Phase 4 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1 Inflammation 1

Interventions

Tea 1 Sufentanil 1 Morphine 1 Ketorolac 1 Ibuprofen 1 Anti-Inflammatory Agents, Non-Steroidal 1 Analgesia, Patient-Controlled 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01367418 2012-03-19

AIMS

Örebro University, Sweden

Phase 3 Completed

Inflammation, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡